Hiroaki Moroi   Kouji Kimura   Tomomi Kotani   Hiroyuki Tsuda   Hirotsugu Banno   Wanchun Jin   Jun-Ichi Wachino   Keiko Yamada   Takashi Mitsui   Mamoru Yamashita   Fumitaka Kikkawa   Yoshichika Arakawa   
Emerging microbes & infections 8(1) 2-7 2019年 [査読有り]
β-Lactam antibiotics are first-line agents for the treatment and prevention of group B Streptococcus (GBS) infections. We previously reported clinical GBS isolates with reduced β-lactam susceptibility (GBS-RBS) and characterized them as harbouring...